Showing results (111-120 of 2,406) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|June 22, 2019
Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspectiveMargaret E Gerbasi, Daniel Stellato, Sameer R Ghate, et al.Journal of Medical Economics|July 3, 2019
Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasisQian Cai, Amanda Teeple, Bingcao Wu, et al.Journal of Medical Economics|June 26, 2019
Characteristics, comorbidities, and use of healthcare resources of patients with phenylketonuria: a population-based studyJosep DarbàJournal of Medical Economics|February 21, 2022
How the cost-effectiveness results change in the China health policy environment: an economic evaluation of glycopyrrolate/formoterol for the treatment of COPDLuying Wang, Weili Gu, Xiao Zhang, et al.Journal of Medical Economics|February 17, 2022
Cost-effectiveness of brentuximab vedotin plus chemotherapy for previously untreated CD30-positive peripheral T-cell lymphoma in CanadaDenise Zou, Joseph Lee, Anuraag Kansal, et al.Journal of Medical Economics|January 24, 2022
Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspectiveJeff Schein, Lenard A Adler, Ann Childress, et al.Journal of Medical Economics|January 24, 2022
Mean lifetime survival estimates following solid organ transplantation in the US and UKChristopher N Graham, Crystal Watson, Arie Barlev, et al.Journal of Medical Economics|March 14, 2022
Urinary catheter monitoring of intra-abdominal pressure after major abdominal surgery, a cost-benefit analysisJohn P Ney, Vanessa Moll, Edward J KimballJournal of Medical Economics|March 15, 2022
How China controls the Covid-19 epidemic through public health expenditure and policy?Hui Jin, Baoyang Li, Mihajlo JakovljevicJournal of Medical Economics|April 7, 2022
Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19Scott Gibson, Rhodri Saunders, Nathan Stasko, et al.Pageof 241